Mutations in a regulator gene (capR) that causes increased synthesis of capsular polysaccharide and derepressed synthesis of several enzymes involved in polysaccharide synthesis also derepress synthesis of guanosine diphosphate (GDP) -mannose pyrophosphorylase. In addition, a second mucoid mutation (capS, which maps separately from capR) also results in the derepression of GDP-mannose pyrophosphorylase. New conditions for assaying GDP-mannose hydrolyase and GDP-Lfucose synthetase permitted us to show that these enzymes are also derepressed in the capS mucoid strain. Although phosphomannose isomerase and uridine diphosphate-galactose-4-epimerase are derepressed in capR mucoid strains, they are not derepressed in capS mucoid strains. A nonmucoid mutant of a strain containing the capR9 (mucoid) allele was deficient in GDP-mannose pyrophosphorylase.
.
However, none of the structural genes for the other enzymes of the GDP-fucose synthesis pathway has been mapped yet. The structural genes for UDP-galactose-4-epimerase (galE) and UDP-glucose pyrophosphorylase (galU) map at different loci than either capR or man ( Fig. 2; reference 20) . Thus, the capR regulator gene controls the expression of several widely separated structural genes.
Independent experiments of Howard-Flanders, Simson, and Theriot (6) and Adler and Hardigree (2) demonstrated that a mutation designated lon-caused E. coli K-12 to become very sensitive to ultraviolet (UV) and ionizing radiation. These lon-strains are mucoid (6) and, after X-ray irradiation, form filaments that die (2) . It is now clear that the phenotypes of capR and Ion mutants are identical, i.e., mucoid and UVsensitive (2, 3, 5, 6, 10, 14) and arise from the same mutational event (5, 14) . The capR and lonmutations are located within the same cistron or at least within two cistrons in the same operon (5, 14) . The designation capR will be used to denote these mutants. CapR mutants are not defective in the repair of irradiated TI or T7 bacteriophage (6; Uretz, unpublished data). The mechanism by which capR controls radiation sensitivity is unknown at the present time.
A mutation at another site has been found which also results in a mucoid cell. This mutation, capS [previously designated R2 (14)], is not linked to proC by transduction and is thus located on a different part of the chromosome than capR. CapS was mapped by time of entry experiments (13) and found to be located about 3 to 4 min after tryptophan in the counterclockwise direction (Fig. 2) . However, some of the enzymes which are derepressed in strains with a capR mucoid mutation are not derepressed in the capS mucoid mutant. The capS mutation also does not affect radiation sensitivity, and capS mucoids are just as resistant to radiation as the nonmucoid wildtype.
More recently further evidence has been obtained to support the supposition that the capR gene product is a protein. It was shown by Kang and Markovitz that when wild-type (capR+) strains were grown in media containing low concentrations of p-fluorophenylalanine (FPA), an amino acid analogue, these wild-type (nonmucoid) strains turned mucoid (8) . Furthermore, these mucoid FPA-phenocopies contained elevated levels of phosphomannose isomerase, UDP-galactose-4-epimerase, and GDP-L-fucose synthetase (8) . These results were interpreted as indicating that the incorporation of the amino acid analogue, FPA, into the capR gene product, possibly the repressor, caused the capR gene product to be inactivated, resulting in derepressed enzymes and increased capsular polysaccharide synthesis.
Another study has shown that mutations in the capR gene which cause radiation sensitivity and increased capsular polysaccharide synthesis are suppressible by ochre suppressors (12) . These mutations, therefore, are nonsense mutations, and the subunits of the repressor which are made from the capR mutant alleles studied are probably incomplete polypeptides.
In this report the problem of the regulation of capsular polysaccharide synthesis was pursued further and the following results were obtained. MC121 and MC122 by transduction with bacteriophage P1 was described previously (13) . Strain MC153 is a nonmucoid mutant of strain MC128, and its genotype is proC, purE, capR9, and non-3 (non is used to designate a nonmucoid mutation in a strain that is derived from a capR9-type mucoid strain). Strain MC120 requires leucine, proline, purine, and tryptophan for growth, and is mucoid. Its genotype is leu-i, proC, purE, trp-1, and capSI. (The capS mucoid mutation is described above.) The isolation of strain MC120 (previously designated 17-57b) was described previously (14) .
Media. M-9 minimal medium (1) was supplemented as described previously (15) . Bacteria were grown aerobically at 25 C for all enzyme studies and disrupted as described previously (8) .
Assays. GDP-4-keto, 6- (11) . The second was a large-scale preparative reaction in exactly the same proportions as the small scale reaction but started 2 hr later. Thus, if the GDPKR level should start to drop in the monitored tube, the preparative reaction could be stopped before the decline in GDPKR concentration occurred. It was found that the GDPKR production continued (as the concentration increased) steadily up to about 22 hr, at which point the GDPKR concentration leveled off and remained the same until 24 hr. The preparative reaction was stopped at this point (22 hr) by boiling the tube for 1 min and centrifuging down the protein precipitate. The resulting supernatant fraction was used as the GDPKR preparation and was assayed with purified GDPKR reductase. From this, the GDPKR concentration was calculated to be about 6.7 ,umoles/ml, indicating a 65% conversion of GDPM to GDPKR in the reaction. However, by adding hydrolyase to the GDPKR assay cuvette (NADPH plus reductase plus boiled GDPKR) after the reaction was complete (all of the GDPKR was used up), one could measure the amount of GDPM left (11) . This was done and it appeared that only about 10% of the GDPM was left. Since only 67% was converted to GDPKR, about 20% of the GDPM is unaccounted for. This might have been reacted with contaminant enzymes in the partially purified hydrolyase used to make the GDPKR, or some of the GDPKR made might have broken down during the 22 hr of incubation. It is also possible that the hydrolyase reaction in the cuvette will not go to completion because of the presence of some inhibitor formed during the reaction.
GDP-mannose pyrophosphorylase was assayed by the method of Preiss (17) (about 106 to 107 counts per min per,mole), 5 ,umoles of NaH2PO4-Na2HPO0 (pH 7.0), and enzyme. The reactions were started with the addition of enzyme. The reaction mixtures were incubated at 37C for 0, 1, 2, 3, or 5 min, and then 3.0 ml of ice-cold 5% trichloroacetic acid containing 0.033 M Na4P207 was added to the reaction tubes, which were then mixed and put on ice. The trichloroacetic acid was added to the zero time sample before substrate (GDP-mannose). Endogenous controls were run along with the assay tubes by preparing reaction tubes identically, but omitting GDP-mannose. The endogenous control tubes were then incubated and handled as described above. The reaction tubes (including the endogenous controls) were then centrifuged at 2,000 rev/min (500 X g) for 20 min in the RC-2B centrifuge (Ivan Sorvall, Inc., Norwalk, Conn.) with the SM24 rotor to remove the precipitated protein. A 0.1-ml amount of a 150 mg/ml of suspension of acid-washed charcoal (Norit A) was added to the supernatant fraction.
The samples were mixed well, and allowed to sit on ice for at least 15 min. The charcoal was then pelleted by centrifugation at 2,000 rev/min for 20 min in the Sorvall centrifuge, washed once with ice-cold 5% trichloroacetic acid (the samples were kept cold at all times), and twice with ice-cold water. After the second water wash, each charcoal sample was eluted by adding 1.0 ml of 50% ethyl alcohol-0.1% NH4OH to it and mixing well. The charcoal suspension in ammoniacal ethyl alcohol was allowed to stand for at least 10 min and then centrifuged. A 0.6-ml amount of the supernatant fraction was counted for radioactivity. The counts obtained in the endogenous controls were subtracted from the counts obtained in the reaction tubes containing GDP-mannose to obtain the net counts/min, i.e., counts incorporated into the 3-and -y-phosphates of guanosine triphosphate (GTP) from the 32P-labeled Na4P207.
Except where otherwise noted, all enzyme assays were performed by using at least two different levels of enzyme. The specific activities obtained were averaged to yield the reported value. The specific activities for GDP-mannose pyrophosphorylase obtained at the two levels were in very close agreement, usually from 2 to 8% of each other. At very low activities (less than 50 nmoles per hour per mg of protein), the differences sometimes were as high as 15%. Phosphomannose isomerase, UDP-galactose-4-epimerase, GDP-mannose hydrolyase, and GDP-L-fucose synthetase were assayed as described previously (7, 8, 10) . The extraction buffer used when assaying the latter two enzymes was modified as described below. Protein concentration was determined by the method of Lowry et al. (9) . Polysaccharide production was estimated as nondialyzable methylpentose in supernatant fractions from boiled cultures by the method of Dische and Shettles (4) .
RESULTS
Derepression of GDP-mannose pyrophosphorylase. Enzymes in the biochemical pathway for capsular polysaccharide synthesis which were not previously assayed in mucoid mutants were assayed in an attempt to find other derepressed enzymes. It was found that GDP-mannose pyrophosphorylase was highly elevated in strain MC121 (which contains the capR9 gene) as well as in strain MC122 (capR6) and strain MC120 (capS mucoid). In vitro assays of this enzyme in mucoid and wild-type strains are shown in Fig. 3 . The figure shows that the assays are linear up to 5 min (except for very high activities). As can be seen, GDP-mannose pyrophosphorylase is derepressed in both capR and capS mucoid mutants. Although other enzymes have previously been found to be derepressed in capR mucoid strains, the finding that this enzyme is also derepressed in the capS mucoid strain is the first finding of a direct enzymatic effect of this mutation. The data on GDP-mannose pyrophosphorylase activities in these strains are summarized in Table 1 and compared with the amount of capsular polysaccharide produced by each strain.
GDP-mannose pyrophosphorylase is derepressed about 22-fold in capR9 mucoid mutants, about 5.5-fold in capR6 mucoid strains, and about 11-fold in the capS mucoid. The 22-fold derepression of this enzyme in the capR9 strain is significantly higher than the level of derepression of PMI and UDP-galactose-4-epimerase previously found in this strain (10, 13) . Strains MC123 (capR9 man-i) and MC125 (capR9 man-2), which were previously found to be deficient in PMI (13) , were also assayed for GDP-mannose pyrophosphorylase activity and were not deficient in this enzyme. The specific activity of GDPmannose pyrophosphorylase was (10) or in the capS mucoid (capR+ capS) strain. It was found that by preparing the extracts in 10-s M ethylenediaminetetraacetic acid (EDTA), 2 X 1O-' M MgCl2 and 0.05 M NaH2PO4-Na2HPO4 (pH 7.0), the specific activity of GDP-L-fucose synthetase in the capR mucoids was higher than previously found in phosphate buffer alone. Moreover, this enzyme could now be clearly detected in the capS mucoid strain and, in some experiments, activity was detected in the wild-type (capR+ capS+) strain. The results of an in vitro assay of GDP-L-fucose synthetase in strain MC120 (capS) and strain MC116 (capS+) are shown in Fig. 4 . The results demonstrate that this enzyme is indeed derepressed in the capS mucoid strain MC120. Furthermore, it was found that GDP-mannose hydrolyase is also depressed in this strain. On the other hand, phosphomannose isomerase and UDP-galactose-4-epimerase were not derepressed in the capS mucoid ( Table 3 ). The specific activities of GDP-mannose pyrophosphorylase, GDP-mannose hydrolyase, and GDP-L-fucose synthetase in the capS mucoid are roughly 50% of that in a capR9 mucoid strain. Nonmucoid mutant deficient in GDP-mannose pyrophosphorylase. Strain MC128, a capR9 mucoid strain, was subjected to mutagenesis by nitrosoguanidine treatment and four nonmucoids were isolated. These nonmucoid mutants were shown by transduction analysis (Markovitz, unpublished results) and enzymatic analysis (Lieberman and Markovitz, unpublished results) to have retained the capR9 allele, but were nonmucoid due either to a mutation in a structural gene for one of the enzymes involved in capsular polysaccharide synthesis, or suppressor mutations. All four of these nonmucoids were assayed for GDP-mannose pyrophosphorylase activity (Table 4) , along with the capsular polysaccharide production of each mutant compared to the capR9 mucoid strain. All four nonmucoids have much less polysaccharide than the capR9 mucoid, although the non-i strain has considerably more polysaccharide than the other three nonmucoids.
The non-i and non-2 strains have the full derepressed level of enzyme activity. The non-4 strain has about half the derepressed level, whereas the non-3 strain was found to be GDPmannose pyrophosphorylase-deficient, having only about 2.5% of the derepressed level of activity as measured in our assay. This deficiency is the probable cause of the nonmucoid phenotype in strain MC153 (capR9 non-3). Extracts of strain MC153 were shown not to contain any inhibitors by experiments with mixed extracts (Table 2) or dialyzed extracts, as described above. Also, since it had previously been shown that, in strains which were deficient in phosphomannose isomerase, growth on mannose-containing media would induce a low level of PMI activity (13, 15) , strain MC153 (capR9 non-3) as well as strains MC117 (capR+ capS+), MC120 (capR+ capS), and MC121 (capR9 capS+) were The results showed that growth on mannose did not induce GDP-mannose pyrophosphorylase activity in the deficient strain (MC153), nor did it affect the activity of this enzyme in the capR9 mucoid, the capS mucoid, or the wild-type (MC117) strains. Strain MC153 (capR9 non-3) was also assayed for PMI and GDP-L-fucose synthetase, and the results showed that this strain contains derepressed levels of both of these enzymes. Thus, a mutation causing a deficiency in GDP-mannose pyrophosphorylase does not affect the activities of PMI and GDP-L-fucose synthetase, enzymes that precede and follow GDP-mannose pyrophosphorylase in the anabolic pathway to GDP-L-fucose.
DISCUSSION
The demonstration of the derepression of GDP-mannose pyrophosphorylase in strains with a mutation in the capR gene adds another enzyme to the list of those that have previously been found to be derepressed in these strains (10, 13) . The level of derepression of GDPmannose pyrophosphorylase in the capR9 strain (22-fold), however, is significantly greater than that previously found for PMI and UDP-galactose-4-epimerase. The level of derepression of GDP-mannose hydrolyase and GDP-L-fucose synthetase was difficult to ascertain precisely, since these two enzymes were barely detectable in the wild-type (capR+) strain by the assay methods used. However, the demonstration of the derepression of GDP-mannose pyrophosphorylase in strains with a capS mutation is the first finding of a direct enzymatic effect of the capS (Table 3) , and such results are consistent with the capS mutation being an operator-constitutive mutation. However, genetic studies are necessary to decide whether the structural genes for GDP-mannose pyrophosphorylase, GDP-mannose-hydrolyase, and GDP-L-fucose synthetase map near capS and are in the same operon. Although PMI and UDP-galactose-4-epimerase are derepressed in capR-type mucoid mutants, these two enzymes are not derepressed in the capS mucoid strain. It is thus clear that the derepression of these two enzymes may accompany a mucoid mutation (capR) but they need not (capS). The fact that GDP-mannose pyrophosphorylase is derepressed in strains MC123 (capR9 man-i) and MC125 (capR9 man-2), both of which are PMI-deficient, makes the possibility of a sequential induction pattern of derepression of the enzymes of the GDP-fucose pathway unlikely. Palleroni and Stanier (16) have described a pattern of sequential induction of some of the enzymes involved in the oxidative dissimilation of L-tryptophan in Pseudomonas fluorescens. A model based on such a pattern might have postulated that the capR9 allele only derepressed PMI and that the product of this reaction, mannose-6-phosphate or one of its metabolites, induces the synthesis of the other enzymes in the pathway, such as GDP-mannose pyrophosphorylase. Thus, the derepression of PMI would result in the accumulation of high concentrations of mannose-6-phosphate, which might, in turn, induce the synthesis of derepressed levels of the other enzymes. However, such an induction pattern has been made unlikely, since the PMIdeficient strains, which would not contain high concentrations of mannose-6-phosphate, are derepressed for GDP-mannose pyrophosphorylase. An analogous hypothesis involving the derepression of GDP-mannose pyrophosphorylase by the capR9 allele and subsequent sequential induction of GDP-mannose hydrolyase and GDP-L-fucose synthetase has also been made unlikely by the fact that the synthetase is derepressed in strain MC153, which is GDPmannose pyrophosphorylase deficient.
